Daily Archives: June 16, 2026

SRIMEDCON 2026: Empowering Faculty for Excellence in Medical Education

A three day international conference on medical education SRIMEDCON 2026 was recently held at Sri Ramachandra Institute of Higher Education and Research. Dr. Lalitbhushan S. Waghmare, Vice Chancellor, Datta Maghe Institute of Higher Education and Research, Maharashtra inaugurated the conference. Medical educators from all over the world discussed innovative approaches …

Read More »

State-level Thirukkural Elocution,Drawing & Essay Contests for School and College Students

Chennai, June 2026 Shriram Ilakkiya Kazhagam, the literary wing of Shriram group, one of India’s leading non-banking financial companies, is organizing Thirukkural Elocution, Drawing & Essay Contests 2026, the annual state-level competition from 18thJuly to 30th Aug. 2026, for School and College students across 12 centres covering Tamil Nadu and Puducherry.  The Chennai zone competitions will be held at CSI Jessie Moses Matriculation Higher Secondary School, Anna Nagar on 29thAugust 2026 and at Vels Vidyashram, Pallavaram on 30th August 2026. The contest at other cities will be held as follows: Salem …

Read More »

CII IWN TN Launches ‘Made in Tamil Nadu’ to Celebrate Women Shaping the State’s Growth Story

Chennai, June 2026: The Confederation of Indian Industry (CII) Indian Women Network (IWN) Tamil Nadu hosted the inaugural edition of ‘Made in Tamil Nadu – Celebrating Women Leading Tamil Nadu’s Growth Story’, becoming the first CII IWN chapter in the country to launch a dedicated annual initiative recognising women whose contributions have significantly shaped …

Read More »

Novartis Deepens Commitment to India with Launch of Pluvicto®, the Country’s First Regulatory Authority Approved Radioligand Therapy for Advanced Prostate Cancer

June 2026 • Prostate cancer is a growing health challenge in India, withover 250,000 cases1 annually and more than half detected atadvanced stages, underscoring the urgent need for earlierdiagnosis and improved access to advanced treatment options. • Radioligand therapy introduces a more targeted treatment approach with the potential to delay disease progression, support overall survival in defined settings, and improve quality of life for patients. • Pluvicto is the country’s first regulatory authority approvedradioligand therapy, marking a significant step forward in precision oncology for advanced prostate cancer. • The launch of Pluvicto reflects Novartis’ continued …

Read More »

istanbul evden eve nakliyat eşya depolama evden eve nakliyat